The protocol of the POSITIVE study, published in the British Medical Journal (BMJ)1, applies the 5-item World Health Organization Wellbeing Index, WHO-5, to capture wellbeing in moderate to severe
Almirall, the first to assess wellbeing in a dermatology clinical study The protocol of the POSITIVE study, published in the British Medical Journal (BMJ)[i], applies the 5-item World Health Organization Wellbeing Index, WHO-5, to capture wellbeing in moderate to severe psoriasis patients under tildrakizumab treatme.
Almirall becomes first to assess well-being as primary endpoint in dermatology study pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.